智能外体增强了PDAC向治疗的作用
Justin F Creeden1, Jonathan Sevier1, Jian-Ting Zhang1
1Department of Cell and Cancer Biology, University of Toledo, Toledo, OH, USA.
概括
工程外体 ("智能外体") 通过改善瘤向和减少清除来增强胰腺癌治疗. 这种新的方法提高了药物输送和癌症治疗的疗效.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 癌症治疗 癌症治疗
背景情况:
- 外体是药物输送的天然纳米载体,但在瘤向和由单核细胞系统 (MPS) 快速清除方面面临挑战.
- 现有的外体治疗因癌细胞的向不佳和循环时间短而受到限制,这阻碍了临床应用.
研究的目的:
- 为了改造外体,提高胰腺管腺癌 (PDAC) 细胞的向和减少MPS清除.
- 在胰腺癌的临床前模型中评估工程外体的治疗疗效.
主要方法:
- 通过CD9修饰,工程外体 (ExoSmart) 通过CD9修饰共同显示RGD和CD47p110-130.
- 评估了ExoSmart在PDAC细胞上与αvβ3的结合以及细胞吸收在体外和体内.
- 评估了ExoSmart与巨细胞 (SIRPα) 的相互作用,以抑制细胞和减少MPS清除.
主要成果:
- ExoSmart表现出对PDAC细胞的增强结合和细胞吸收的增加.
- 工程外体显示肝脏和脏的清除减少,这是由于抑制了巨细胞化.
- 在用ExoSmart治疗的PDAC模型中观察到化学治疗效率的增加.
结论:
- 工程外体 (ExoSmart) 代表了增强胰腺癌治疗的有希望的战略.
- 这种方法改善了PDAC的向性,并延长了循环时间,为癌症治疗提供了显著的翻译潜力.
- 新型体工程外体战略为以外体为基础的药物输送的未来进展提供了基础.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K


